JP2005504006A5 - - Google Patents

Download PDF

Info

Publication number
JP2005504006A5
JP2005504006A5 JP2002580872A JP2002580872A JP2005504006A5 JP 2005504006 A5 JP2005504006 A5 JP 2005504006A5 JP 2002580872 A JP2002580872 A JP 2002580872A JP 2002580872 A JP2002580872 A JP 2002580872A JP 2005504006 A5 JP2005504006 A5 JP 2005504006A5
Authority
JP
Japan
Prior art keywords
group
alkyl
compound
compound according
heteroalkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002580872A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005504006A (ja
Filing date
Publication date
Priority claimed from US10/066,306 external-priority patent/US6774116B2/en
Application filed filed Critical
Publication of JP2005504006A publication Critical patent/JP2005504006A/ja
Publication of JP2005504006A5 publication Critical patent/JP2005504006A5/ja
Pending legal-status Critical Current

Links

JP2002580872A 2001-04-17 2002-04-12 シンナメートとのアシル化によるプロドラッグ結合 Pending JP2005504006A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28430401P 2001-04-17 2001-04-17
US31578201P 2001-08-28 2001-08-28
US10/066,306 US6774116B2 (en) 2001-04-17 2002-01-31 Prodrugs via acylation with cinnamate
PCT/US2002/011330 WO2002083067A2 (en) 2001-04-17 2002-04-12 Prodrugs via acylation with cinnamate

Publications (2)

Publication Number Publication Date
JP2005504006A JP2005504006A (ja) 2005-02-10
JP2005504006A5 true JP2005504006A5 (enExample) 2005-12-22

Family

ID=27370948

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002580872A Pending JP2005504006A (ja) 2001-04-17 2002-04-12 シンナメートとのアシル化によるプロドラッグ結合

Country Status (5)

Country Link
US (1) US6774116B2 (enExample)
EP (1) EP1395256A4 (enExample)
JP (1) JP2005504006A (enExample)
CA (1) CA2444264A1 (enExample)
WO (1) WO2002083067A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157458B2 (en) * 2001-04-17 2007-01-02 Cryolife, Inc. Bifunctional energy-reversible acyl-compositions
AU2002953533A0 (en) * 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
US7432331B2 (en) 2002-12-31 2008-10-07 Nektar Therapeutics Al, Corporation Hydrolytically stable maleimide-terminated polymers
CN100343304C (zh) 2002-12-31 2007-10-17 尼克塔治疗亚拉巴马公司 水解稳定的马来酰亚胺封端的聚合物
AU2004285037B2 (en) * 2003-10-29 2010-07-22 Sonus Pharmaceuticals, Inc. Tocopherol-modified therapeutic drug compounds
US20080119421A1 (en) * 2003-10-31 2008-05-22 Jack Tuszynski Process for treating a biological organism
US6887952B1 (en) * 2004-02-12 2005-05-03 Biosite, Inc. N-aryl-carbamic acid ester-derived and valeric acid ester-derived cross-linkers and conjugates, and methods for their synthesis and use
US20080177220A1 (en) * 2006-01-06 2008-07-24 The Curators Of The University Of Missouri Ultrasound-Mediated Transcleral Drug Delivery
FR2902792A1 (fr) * 2006-06-21 2007-12-28 Servier Lab Nouveaux derives cinnamates de tetrahydro-7h-pyrano(2,3-c)acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2693645A1 (en) * 2007-07-11 2009-01-15 Enzon Pharmaceuticals, Inc. Polymeric drug delivery systems containing an aromatic allylic acid
CA2698812A1 (en) * 2007-09-14 2009-03-19 Nitto Denko Corporation Drug carriers
US20100068254A1 (en) * 2008-09-16 2010-03-18 Mahalaxmi Gita Bangera Modifying a medicament availability state of a final dosage form
US20100068275A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Personalizable dosage form
US20100068233A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Modifiable dosage form
US20100068153A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex vivo activatable final dosage form
US20100068235A1 (en) * 2008-09-16 2010-03-18 Searete LLC, a limited liability corporation of Deleware Individualizable dosage form
US20100068283A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex VIVO modifiable particle or polymeric material medicament carrier
US20100069821A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex vivo modifiable medicament release-sites final dosage form
US20100068152A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex vivo modifiable particle or polymeric based final dosage form
BR112014017517A2 (pt) * 2012-01-27 2017-06-13 Hoffmann La Roche composto, composição farmacêutica, método de tratamento de inflamações, uso de composto e invenção
GB2528643A (en) * 2014-07-08 2016-02-03 Adc Biotechnology Ltd Method of synthesising ADCs
CN117982673A (zh) 2017-02-28 2024-05-07 第一三共株式会社 抗her3抗体-药物偶联物的应用
CN107365283B (zh) * 2017-08-07 2020-12-08 无锡紫杉药业有限公司 一种紫杉醇光降解获得杂质的方法
WO2020059772A1 (ja) 2018-09-20 2020-03-26 第一三共株式会社 抗ｈｅｒ３抗体－薬物コンジュゲート投与によるｈｅｒ３変異がんの治療
CN113101372B (zh) * 2019-12-24 2025-02-14 北京大学 具有辐射响应基团的缀合物及其用途
WO2025002105A1 (zh) * 2023-06-26 2025-01-02 北京大学 可通过辐射激活的化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX169489B (es) * 1987-12-28 1993-07-07 Sumitomo Chemical Co Procedimiento para preparar compuestos de estirilo
US5114851A (en) * 1989-08-29 1992-05-19 Duke University Light activated acyl-enzymes
US5218137A (en) * 1989-08-29 1993-06-08 Duke University Light activated acyl-enzymes
EP0936211B1 (en) * 1998-02-13 2010-07-07 Givaudan SA Aryl-acrylic acid esters useful as precursors for organoleptic compounds
JP2000319202A (ja) * 1999-01-12 2000-11-21 Bunshi Biophotonics Kenkyusho:Kk 新規ケージド化合物調製用試薬、及びケージド化方法
JP2000264868A (ja) * 1999-01-12 2000-09-26 Bunshi Biophotonics Kenkyusho:Kk 新規ケージドアミノ酸

Similar Documents

Publication Publication Date Title
JP2005504006A5 (enExample)
AU730244B2 (en) High molecular weight polymer-based prodrugs
US6127355A (en) High molecular weight polymer-based prodrugs
JP2007530441A5 (enExample)
US6294697B1 (en) Discrete-length polyethylene glycols
JP2020514300A5 (enExample)
CA2669541C (en) Method for preparing a polymer conjugate
JP2006505634A5 (enExample)
JP2011528654A5 (enExample)
JP2002508400A5 (enExample)
CN101541332A (zh) 含多官能连接基的靶向聚合物前药
JP2010503706A (ja) リジン系ポリマーリンカー
AU6488099A (en) Dds compounds and method for assaying the same
JP2003503370A5 (enExample)
JP2005538035A5 (enExample)
RU2002128610A (ru) Композиция конъюгатов полиглутаминовой кислоты с камптотецином (варианты) и способ ее получения (варианты), фармацевтическая композиция (варианты) и способ лечения лейкоза или плотной опухоли
RU2005141550A (ru) Высвобождаемые полимерные конъюгаты на основе алифатических биоразлагаемых сшивающих агентов
CN101835482A (zh) 含吡啶基二硫化物部分的聚合连接基
KR20050111586A (ko) 드러그 및 유전자 전달 시스템으로서의 다기능의 덴드리머및 다중결합된 폴리머
EP3072910A1 (en) Derivative of styrene-maleic acid copolymer
KR20080013883A (ko) 시티딘계 대사길항제의 고분자 유도체
US20240158445A1 (en) Cyclic cell-penetrating peptides with three or more hydrophobic residues
JP2008523239A5 (enExample)
US20050085417A1 (en) Compounds and methods for diagnostic imaging and therapy
EP1857459A3 (en) Pyrazolopyrimidine compound and a process for preparing the same